|
| Factor | Odds ratio | 95% CI | P value |
|
| Overall tumor recurrences | | | |
| Age (>60 years) | 1.300 | 0.619–2.729 | 0.489 |
| Histology* | 1.092 | 0.556–2.147 | 0.798 |
| FIGO grade (3 versus 1-2) | 3.726 | 1.957–7.095 | 0.00006 |
| Nuclear grade (3 versus 1-2) | 1.713 | 0.878–3.341 | 0.114 |
| DNA ploidy** | 1.669 | 1.071–2.602 | 0.024 |
| Myometrial infiltration*** | 2.077 | 1.392–3.098 | 0.0003 |
|
| Distant tumor recurrences | | | |
| Age (>60 years) | 0.844 | 0.377–1.889 | 0.680 |
| Histology* | 1.155 | 0.572–2.330 | 0.689 |
| FIGO grade (3 versus 1-2) | 4.750 | 2.319–9.729 | 0.00002 |
| Nuclear grade (3 versus 1-2) | 1.686 | 0.809–3.515 | 0.163 |
| DNA ploidy** | 1.805 | 1.101–2.957 | 0.019 |
| Myometrial infiltration*** | 2.853 | 1.784–4.565 | 0.00001 |
|